Offer - Urjas Oil for just ₹ 1 X
Biorubin 50 Injection is a prescription medicine that is available as a Injection. It is primarily used for the treatment of Breast Cancer.
The right dosage of Biorubin 50 Injection depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
While these are the most often observed Biorubin 50 Injection side effects, there are can be others also. These have been listed below. Such side effects of Biorubin 50 Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Biorubin 50 Injection's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Biorubin 50 Injection's effects on the liver, heart and kidney are discussed below in the Biorubin 50 Injection related warnings section.
Other contraindications of Biorubin 50 Injection have been discussed in the sections ahead.
Additionally, Biorubin 50 Injection may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Biorubin 50 Injection is not safe while driving, and is is not addictive in nature.
Biorubin 50 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Is the use of Biorubin 50 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Biorubin. If you are pregnant, do not take Biorubin without a doctor's advice.
Is the use of Biorubin 50 Injection safe during breastfeeding?
Taking Biorubin may lead to serious side effects if you are breastfeeding. Biorubin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Biorubin 50 Injection on the Kidneys?
There can be some harmful effects on your kidneys after taking Biorubin. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Biorubin 50 Injection on the Liver?
You may experience side effects on your liver after taking Biorubin. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Biorubin 50 Injection on the Heart?
Biorubin may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Biorubin 50 Injection unless your doctor advises you to do so -
Is this Biorubin 50 Injection habit forming or addictive?
No, you will not get addicted to Biorubin 50 Injection.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Biorubin 50 Injection can make you feel drowsy.
Is it safe?
Biorubin 50 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Biorubin 50 Injection cannot treat any kind of mental disorder.
Interaction between Food and Biorubin 50 Injection
Taking Biorubin 50 Injection with food does not cause any problems.
Interaction between Alcohol and Biorubin 50 Injection
Consumption of alcohol and Biorubin 50 Injection together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ellence® (epirubicin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 505-508